Department of Anesthesiology and Reanimation, Ege University School of Medicine, Izmir, Turkey.
Minerva Anestesiol. 2010 Feb;76(2):115-9. Epub 2009 Dec 23.
The aim of this prospective study was to investigate whether the neuromuscular response to rocuronium is affected by the presence of type 2 diabetes mellitus.
Neuromuscular functions were measured after the administration of 0.6 mg/kg rocuronium with train-of-four stimulations in patients with type 2 diabetes mellitus (DM, N=14) and without diabetes mellitus (control, N=14) during isoflurane based general anesthesia. The onset time, clinical duration and recovery index of rocuronium were compared in the two groups.
The mean onset time (136 +/- 40 vs 118 +/- 20 s), clinical duration (51 +/- 11 vs 48 +/- 11 min) and recovery index (6.0 +/- 2.5 vs 5.9 +/- 1.4 min) of the neuromuscular block were not significantly different between the DM and control groups, respectively (p>0.05).
The present study has proven that the rocuronium-induced neuromuscular block was not affected in patients with type 2 diabetes mellitus during isoflurane based general anesthesia.
本前瞻性研究旨在探讨 2 型糖尿病患者中罗库溴铵的神经肌肉反应是否受其影响。
在异氟醚全身麻醉下,用四脉冲刺激给予 0.6mg/kg 罗库溴铵后,测量 2 型糖尿病(DM,N=14)和无糖尿病(对照组,N=14)患者的神经肌肉功能。比较两组罗库溴铵的起效时间、临床持续时间和恢复指数。
DM 组和对照组的平均起效时间(136 +/- 40 对 118 +/- 20 s)、临床持续时间(51 +/- 11 对 48 +/- 11 min)和恢复指数(6.0 +/- 2.5 对 5.9 +/- 1.4 min)差异均无统计学意义(p>0.05)。
本研究证明,在异氟醚全身麻醉下,2 型糖尿病患者的罗库溴铵诱导的神经肌肉阻滞不受影响。